Raymond Y. Cho - Publications

Affiliations: 
University of Pittsburgh, Pittsburgh, PA, United States 
Area:
schizophrenia, cognitive control

46 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2020 Murphy N, Ramakrishnan N, Walker CP, Polizzotto NR, Cho RY. Intact Auditory Cortical Cross-Frequency Coupling in Early and Chronic Schizophrenia. Frontiers in Psychiatry. 11: 507. PMID 32581881 DOI: 10.3389/fpsyt.2020.00507  0.8
2020 Polizzotto NR, Ramakrishnan N, Cho RY. Is It Possible to Improve Working Memory With Prefrontal tDCS? Bridging Currents to Working Memory Models. Frontiers in Psychology. 11: 939. PMID 32528366 DOI: 10.3389/fpsyg.2020.00939  0.8
2019 Ramakrishnan N, Murphy NRE, Walker CP, Cuellar Leal VA, Soares JC, Cho RYJ, Selvaraj S. Neurophysiological Effect of Ketamine on Prefrontal Cortex in Treatment-Resistant Depression: A Combined Transcranial Magnetic Stimulation-Electroencephalography Study. Chronic Stress (Thousand Oaks, Calif.). 3: 2470547019861417. PMID 32440596 DOI: 10.1177/2470547019861417  0.8
2019 Walker CP, Pessoa ALS, Figueiredo T, Rafferty M, Melo US, Nóbrega PR, Murphy N, Kok F, Zatz M, Santos S, Cho RY. Loss-of-function mutation in inositol monophosphatase 1 (IMPA1) results in abnormal synchrony in resting-state EEG. Orphanet Journal of Rare Diseases. 14: 3. PMID 30616629 DOI: 10.1186/s13023-018-0977-1  0.8
2018 Schreiber SR, Wojtalik JA, Walker CP, Cho RY, Eack SM, Keshavan MS. Serum anticholinergicity is associated with reduced prefrontal brain function in early course schizophrenia. Psychiatry Research. Neuroimaging. 281: 31-34. PMID 30216862 DOI: 10.1016/j.pscychresns.2018.08.017  0.8
2018 Cao B, Cho RY, Chen D, Xiu M, Wang L, Soares JC, Zhang XY. Treatment response prediction and individualized identification of first-episode drug-naïve schizophrenia using brain functional connectivity. Molecular Psychiatry. PMID 29921920 DOI: 10.1038/s41380-018-0106-5  0.52
2018 Polizzotto NR, Hill-Jarrett T, Walker C, Cho RY. Normal development of context processing using the AXCPT paradigm. Plos One. 13: e0197812. PMID 29852005 DOI: 10.1371/journal.pone.0197812  0.8
2018 Cao B, Luo Q, Fu Y, Du L, Qiu T, Yang X, Chen X, Chen Q, Soares JC, Cho RY, Zhang XY, Qiu H. Predicting individual responses to the electroconvulsive therapy with hippocampal subfield volumes in major depression disorder. Scientific Reports. 8: 5434. PMID 29615675 DOI: 10.1038/s41598-018-23685-9  0.52
2018 Xiu MH, Wang D, Chen S, Du XD, Chen DC, Chen N, Wang YC, Yin G, Zhang Y, Tan YL, Cho RY, Soares JC, Zhang XY. Interleukin-3, symptoms and cognitive deficits in first-episode drug-naïve and chronic medicated schizophrenia. Psychiatry Research. 263: 147-153. PMID 29554544 DOI: 10.1016/j.psychres.2018.02.054  0.52
2016 Keshavan MS, Eack SM, Prasad KM, Haller CS, Cho RY. Longitudinal functional brain imaging study in early course schizophrenia before and after cognitive enhancement therapy. Neuroimage. PMID 27894892 DOI: 10.1016/j.neuroimage.2016.11.060  0.52
2016 Girgis RR, Van Snellenberg JX, Glass A, Kegeles LS, Thompson JL, Wall M, Cho RY, Carter CS, Slifstein M, Abi-Dargham A, Lieberman JA. A proof-of-concept, randomized controlled trial of DAR-0100A, a dopamine-1 receptor agonist, for cognitive enhancement in schizophrenia. Journal of Psychopharmacology (Oxford, England). PMID 26966119 DOI: 10.1177/0269881116636120  1
2016 Polizzotto NR, Takahashi T, Walker CP, Cho RY. Wide range multiscale entropy changes through development Entropy. 18. DOI: 10.3390/e18010012  1
2015 Hamilton JE, Heads AM, Cho RY, Lane SD, Soares JC. Racial disparities during admission to an academic psychiatric hospital in a large urban area. Comprehensive Psychiatry. 63: 113-22. PMID 26555499 DOI: 10.1016/j.comppsych.2015.08.010  1
2015 Frankle WG, Cho RY, Prasad KM, Mason NS, Paris J, Himes ML, Walker C, Lewis DA, Narendran R. In Vivo Measurement of GABA Transmission in Healthy Subjects and Schizophrenia Patients. The American Journal of Psychiatry. appiajp201514081031. PMID 26133962 DOI: 10.1176/appi.ajp.2015.14081031  1
2015 Gonzalez-Burgos G, Cho RY, Lewis DA. Alterations in Cortical Network Oscillations and Parvalbumin Neurons in Schizophrenia. Biological Psychiatry. 77: 1031-1040. PMID 25863358 DOI: 10.1016/j.biopsych.2015.03.010  1
2015 Cho RY, Walker CP, Polizzotto NR, Wozny TA, Fissell C, Chen CM, Lewis DA. Development of sensory gamma oscillations and cross-frequency coupling from childhood to early adulthood. Cerebral Cortex (New York, N.Y. : 1991). 25: 1509-18. PMID 24334917 DOI: 10.1093/cercor/bht341  1
2014 Kirli KK, Ermentrout GB, Cho RY. Computational study of NMDA conductance and cortical oscillations in schizophrenia. Frontiers in Computational Neuroscience. 8: 133. PMID 25368573 DOI: 10.3389/fncom.2014.00133  1
2014 Meyer T, Walker C, Cho RY, Olson CR. Image familiarization sharpens response dynamics of neurons in inferotemporal cortex. Nature Neuroscience. 17: 1388-94. PMID 25151263 DOI: 10.1038/nn.3794  1
2014 Forster SE, Cho RY. Context specificity of post-error and post-conflict cognitive control adjustments. Plos One. 9: e90281. PMID 24603900 DOI: 10.1371/journal.pone.0090281  1
2014 Cho R, Wu W. Is inner speech the basis of auditory verbal hallucination in schizophrenia? Frontiers in Psychiatry. 5. DOI: 10.3389/fpsyt.2014.00075  1
2014 Cho RY. Cognitive behaviour therapy for command hallucinations The Lancet Psychiatry. 1: 3-5. DOI: 10.1016/S2215-0366(14)70256-1  1
2013 Richard AE, Carter CS, Cohen JD, Cho RY. Persistence, diagnostic specificity and genetic liability for context-processing deficits in schizophrenia. Schizophrenia Research. 147: 75-80. PMID 23570894 DOI: 10.1016/j.schres.2013.02.020  1
2013 Kieffaber PD, Kruschke JK, Cho RY, Walker PM, Hetrick WP. Dissociating stimulus-set and response-set in the context of task-set switching. Journal of Experimental Psychology. Human Perception and Performance. 39: 700-19. PMID 22984990 DOI: 10.1037/a0029545  1
2013 Cho R, Wu W. Mechanisms of auditory verbal hallucination in schizophrenia Frontiers in Psychiatry. 4. DOI: 10.3389/fpsyt.2013.00155  1
2012 Kömek K, Bard Ermentrout G, Walker CP, Cho RY. Dopamine and gamma band synchrony in schizophrenia--insights from computational and empirical studies. The European Journal of Neuroscience. 36: 2146-55. PMID 22805060 DOI: 10.1111/j.1460-9568.2012.08071.x  1
2012 Frankle WG, Cho RY, Mason NS, Chen CM, Himes M, Walker C, Lewis DA, Mathis CA, Narendran R. [11C]flumazenil binding is increased in a dose-dependent manner with tiagabine-induced elevations in GABA levels. Plos One. 7: e32443. PMID 22384252 DOI: 10.1371/journal.pone.0032443  1
2011 Lee H, Kane I, Sereika SM, Cho RY, Jolley CJ. Medication-taking behaviours in young adults with schizophrenia: a pilot study. Journal of Psychiatric and Mental Health Nursing. 18: 418-24. PMID 21539687 DOI: 10.1111/j.1365-2850.2011.01689.x  1
2011 Forster SE, Carter CS, Cohen JD, Cho RY. Parametric manipulation of the conflict signal and control-state adaptation. Journal of Cognitive Neuroscience. 23: 923-35. PMID 20146615 DOI: 10.1162/jocn.2010.21458  1
2010 Kieffaber PD, Cho RY. Induced cortical gamma-band oscillations reflect cognitive control elicited by implicit probability cues in the preparing-to-overcome-prepotency (POP) task. Cognitive, Affective & Behavioral Neuroscience. 10: 431-40. PMID 21098804 DOI: 10.3758/CABN.10.4.431  1
2010 Eack SM, Hogarty GE, Cho RY, Prasad KM, Greenwald DP, Hogarty SS, Keshavan MS. Neuroprotective effects of cognitive enhancement therapy against gray matter loss in early schizophrenia: results from a 2-year randomized controlled trial. Archives of General Psychiatry. 67: 674-82. PMID 20439824 DOI: 10.1001/archgenpsychiatry.2010.63  1
2010 Mizuno T, Takahashi T, Cho RY, Kikuchi M, Murata T, Takahashi K, Wada Y. Assessment of EEG dynamical complexity in Alzheimer's disease using multiscale entropy. Clinical Neurophysiology : Official Journal of the International Federation of Clinical Neurophysiology. 121: 1438-46. PMID 20400371 DOI: 10.1016/j.clinph.2010.03.025  1
2010 Takahashi T, Cho RY, Mizuno T, Kikuchi M, Murata T, Takahashi K, Wada Y. Antipsychotics reverse abnormal EEG complexity in drug-naive schizophrenia: a multiscale entropy analysis. Neuroimage. 51: 173-82. PMID 20149880 DOI: 10.1016/j.neuroimage.2010.02.009  1
2009 Cho RY, Orr JM, Cohen JD, Carter CS. Generalized signaling for control: evidence from postconflict and posterror performance adjustments. Journal of Experimental Psychology. Human Perception and Performance. 35: 1161-77. PMID 19653756 DOI: 10.1037/a0014491  1
2009 Takahashi T, Cho RY, Murata T, Mizuno T, Kikuchi M, Mizukami K, Kosaka H, Takahashi K, Wada Y. Age-related variation in EEG complexity to photic stimulation: a multiscale entropy analysis. Clinical Neurophysiology : Official Journal of the International Federation of Clinical Neurophysiology. 120: 476-83. PMID 19231279 DOI: 10.1016/j.clinph.2008.12.043  1
2009 Frankle WG, Cho RY, Narendran R, Mason NS, Vora S, Litschge M, Price JC, Lewis DA, Mathis CA. Tiagabine increases [11C]flumazenil binding in cortical brain regions in healthy control subjects. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 34: 624-33. PMID 18615011 DOI: 10.1038/npp.2008.104  1
2008 Lewis DA, Cho RY, Carter CS, Eklund K, Forster S, Kelly MA, Montrose D. Subunit-selective modulation of GABA type A receptor neurotransmission and cognition in schizophrenia. The American Journal of Psychiatry. 165: 1585-93. PMID 18923067 DOI: 10.1176/appi.ajp.2008.08030395  1
2006 Cho RY, Konecky RO, Carter CS. Impairments in frontal cortical gamma synchrony and cognitive control in schizophrenia. Proceedings of the National Academy of Sciences of the United States of America. 103: 19878-83. PMID 17170134 DOI: 10.1073/pnas.0609440103  1
2005 Snitz BE, MacDonald A, Cohen JD, Cho RY, Becker T, Carter CS. Lateral and medial hypofrontality in first-episode schizophrenia: functional activity in a medication-naive state and effects of short-term atypical antipsychotic treatment. The American Journal of Psychiatry. 162: 2322-9. PMID 16330597 DOI: 10.1176/appi.ajp.162.12.2322  1
2005 Cho RY, Ford JM, Krystal JH, Laruelle M, Cuthbert B, Carter CS. Functional neuroimaging and electrophysiology biomarkers for clinical trials for cognition in schizophrenia. Schizophrenia Bulletin. 31: 865-9. PMID 16166611 DOI: 10.1093/schbul/sbi050  1
2004 Kerns JG, Cohen JD, MacDonald AW, Cho RY, Stenger VA, Carter CS. Anterior cingulate conflict monitoring and adjustments in control. Science (New York, N.Y.). 303: 1023-6. PMID 14963333 DOI: 10.1126/science.1089910  1
2002 Jones AD, Cho RY, Nystrom LE, Cohen JD, Braver TS. A computational model of anterior cingulate function in speeded response tasks: effects of frequency, sequence, and conflict. Cognitive, Affective & Behavioral Neuroscience. 2: 300-17. PMID 12641175  1
2002 Cho RY, Nystrom LE, Brown ET, Jones AD, Braver TS, Holmes PJ, Cohen JD. Mechanisms underlying dependencies of performance on stimulus history in a two-alternative forced-choice task. Cognitive, Affective & Behavioral Neuroscience. 2: 283-99. PMID 12641174  1
2000 Cho RY, Yang V, Hallett PE. Reliability and dimensionality of judgments of visually textured materials. Perception & Psychophysics. 62: 735-52. PMID 10883582  1
1999 Meyer JH, Cho R, Kennedy S, Kapur S. The effects of single dose nefazodone and paroxetine upon 5-HT(2A) binding potential in humans using [18F]-setoperone PET Psychopharmacology. 144: 279-281. PMID 10435395 DOI: 10.1007/s002130051004  1
1999 Kapur S, Cho R, Jones C, McKay G, Zipursky RB. Is amoxapine an atypical antipsychotic? Positron-emission tomography investigation of its dopamine2 and serotonin2 occupancy Biological Psychiatry. 45: 1217-1220. PMID 10331115 DOI: 10.1016/S0006-3223(98)00204-2  1
1999 Cho R, Kapur S, Du L, Hrdina P. Relationship between central and peripheral serotonin 5-HT(2A) receptors: A positron emission tomography study in healthy individuals Neuroscience Letters. 261: 139-142. PMID 10081968 DOI: 10.1016/S0304-3940(98)00998-7  1
Show low-probability matches.